CD163 and embryonal rhabdomyosarcoma: Evidence from embryonal rhabdomyosarcomas indicates that higher densities of CD163+ macrophages can correlate with better survival, potentially due to their interactions with other immune components, such as CD54+ microvessels, which enhance immune cell recruitment [25].